Published in:

01-10-2003

Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

Authors: John H. Sampson, Gamal Akabani, Gary E. Archer, Darell D. Bigner, Mitchel S. Berger, Allan H. Friedman, Henry S. Friedman, James E. Herndon II, Sandeep Kunwar, Steve Marcus, Roger E. McLendon, Alison Paolino, Kara Penne, James Provenzale, Jennifer Quinn, David A. Reardon, Jeremy Rich, Timothy Stenzel, Sandra Tourt-Uhlig, Carol Wikstrand, Terence Wong, Roger Williams, Fan Yuan, Michael R. Zalutsky, Ira Pastan

Published in: Journal of Neuro-Oncology | Issue 1/2003